Targeted Combined Endpoint Improvement in Patient and Disease Domains in Atopic Dermatitis: A Treat-to-Target Analysis of Adults with Moderate-to-Severe Atopic Dermatitis Treated with Upadacitinib

• Autors principals: Shawn G. Kwatra (Autor), Marjolein de Bruin-Weller (Autor), Jonathan I. Silverberg (Autor), Peter Lio (Autor), Mette Deleuran (Autor), Handan Aydin (Autor), Brian M. Calimlim (Autor), Michael C. Lane (Autor), Yingyi Liu (Autor), Sarah Ofori (Autor), Stephan Weidinger (Autor)
• Format: Llibre
• Publicat: Medical Journals Sweden, 2024-05-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

A treat-to-target approach was recently developed to guide systemic treatment for adults with atopic dermatitis (AD). Recommendations outlined criteria for a 3-month initial acceptable treatment target and a 6-month optimal target, evaluated using global assessment of patient-reported disease severi...